Saroglitazar From Diabetic Capital Of India

Mar. 21 | Pharma major Cadila Healthcare has been working on a molecule for diabetes dyslipidemia, to be called ‘Saroglitizar’. The name is believed to have been derived from the Gujarati word ‘saro’, meaning good. The company may soon become...

FDA Approved BELVIQ, The Obesity Drug In 13 Years

Jun. 29 | The U.S. Food and Drug Administration (FDA) approved BELVIQ (pronounced BEL-VEEK) as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m2or...